BRIEF published on 01/19/2026 at 13:01, 8 months 21 days ago Viromed Medical AG franchit une étape importante avec une étude pulmonaire ex vivo Recherche Médicale Viromed Medical AG Technologie Du Plasma Froid Étude Pulmonaire Ex Vivo Progrès Pharmaceutique
BRIEF published on 01/19/2026 at 13:01, 8 months 21 days ago Viromed Medical AG Achieves Milestone with Ex-Vivo Lung Study Medical Research Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study Pharmaceutical Advancement
PRESS RELEASE published on 01/19/2026 at 12:56, 8 months 21 days ago Correction of a release from 19/01/2026, 11:45 CET/CEST - Viromed Medical AG: Ex-vivo lung study marks milestone for research and approval Viromed Medical AG to conduct ex-vivo lung study on vital lungs in cooperation with universities for accelerated research and approval processes Medical Technology Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study Research Milestone
BRIEF published on 01/19/2026 at 11:50, 8 months 21 days ago Viromed Medical AG fait progresser son étude pulmonaire ex vivo Viromed Medical AG Technologie Du Plasma Froid Étude Pulmonaire Ex Vivo Accélération De La Recherche Préclinique Collaboration De L'Université De La Sarre
BRIEF published on 01/19/2026 at 11:50, 8 months 21 days ago Viromed Medical AG Advances with Ex-Vivo Lung Study Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study Preclinical Research Acceleration Saarland University Collaboration
PRESS RELEASE published on 01/19/2026 at 11:45, 8 months 21 days ago Viromed Medical AG: Ex-vivo lung study marks milestone for research and approval Viromed Medical AG's ex-vivo lung study with Saarland University and MHH is a significant milestone for research & approval, accelerating development processes Research Approval Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study
BRIEF published on 01/15/2026 at 09:53, 8 months 25 days ago Viromed Medical AG Transitions to Registered Shares Shareholders Stock Exchange Viromed Medical AG Registered Shares Cold Plasma Technology
BRIEF published on 01/15/2026 at 09:53, 8 months 25 days ago Viromed Medical AG passe aux actions nominatives Actionnaires Bourse Viromed Medical AG Actions Nominatives Technologie Du Plasma Froid
PRESS RELEASE published on 01/15/2026 at 09:48, 8 months 25 days ago Viromed Medical AG switches to registered shares Viromed Medical AG converts share capital from bearer shares to registered shares to enhance transparency and direct shareholder communication. Stock trading to commence under new ISIN DE000A40VZN7 Stock Exchange Transparency Viromed Medical AG Registered Shares Bearer Shares
BRIEF published on 01/07/2026 at 14:20, 9 months 2 days ago Viromed AG Shares Strategic Update on MedTech Advancements Respiratory Diseases Global Partnerships Innovative Medical Devices Viromed Medical AG Cold Plasma Technology
Published on 10/09/2026 at 14:00, 6 hours 38 minutes ago Stillwater Critical Minerals Upgrades to OTCQX Best Market, Expanding U.S. Market Presence
Published on 10/09/2026 at 14:00, 6 hours 38 minutes ago Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer
Published on 10/09/2026 at 13:23, 7 hours 15 minutes ago SLAM Exploration Announces Leadership Transition and Appointment of Jimmy Gravel as President and CEO
Published on 10/09/2026 at 13:00, 7 hours 38 minutes ago Horizon Aircraft Reports Fiscal 2027 First Quarter Results and Advances Full-Scale Cavorite X7 Development
Published on 10/09/2026 at 13:00, 7 hours 38 minutes ago Nepra Foods Launches Flagship PROPASTA Brand on Amazon
Published on 10/09/2026 at 19:22, 1 hour 16 minutes ago EQS-Adhoc: elumeo SE switches financial reporting to comply with the German Commercial Code (HGB) and refines forecast for 2026
Published on 10/09/2026 at 18:00, 2 hours 38 minutes ago ARVERNE GROUP: Arverne franchit une étape majeure : l'Europe fait du projet Lithium de France un pilier de sa souveraineté industrielle
Published on 10/09/2026 at 18:00, 2 hours 38 minutes ago ARVERNE GROUP: Arverne reaches a major milestone: Europe recognizes the Lithium de France Project as a pillar of its industrial sovereignty
Published on 10/09/2026 at 18:00, 2 hours 38 minutes ago Private Equity Holding AG: Net Asset Value as of September 30, 2026
Published on 10/09/2026 at 19:27, 1 hour 11 minutes ago Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/09/2026 at 19:27, 1 hour 11 minutes ago Déclaration hebdomadaire d'opérations effectuées du 1er au 9 octobre 2026
Published on 10/09/2026 at 17:45, 2 hours 53 minutes ago Déclaration des droits de vote à fin septembre 2026
